A groundbreaking discovery at the University of Saskatchewan may revolutionize the calving season for beef producers. Cetrorelix, a hormone drug commonly used in human IVF, has shown great promise for use in cattle reproduction. Dr. Jaswant Singh, along with graduate students Dylan Farmer and Carlos Leonardi, found that the drug effectively synchronizes ovulation in cows, leading to simultaneous pregnancies and potentially shorter calving periods.
This innovative method could significantly reduce labor costs and improve herd management by ensuring calves are born around the same time. Garner Deobald, a beef rancher and marketing manager at BoviGen Genetic Services, expressed enthusiasm for incorporating Cetrorelix into their breeding practices if proven effective. The drug may also promote artificial insemination as a preferred breeding technique, offering enhanced genetic control and calf predictability.
The University of Saskatchewan has applied for a patent on Cetrorelix and is collaborating with pharmaceutical companies to bring it to market. Dr. Singh is optimistic about the drug’s global impact, anticipating increased use of artificial insemination in livestock production. With promising results in animals and progress in regulatory processes, Cetrorelix holds significant potential for transforming cattle breeding practices worldwide.